Challenges in vaccinating infants born to mothers taking immunoglobulin biologicals during pregnancy

Anti-TNF Therapy and Pregnancy in Inflammatory Bowel Disease: A Prospective Cohort Study From the GETAID

(2018) Mariam Seirafi et al.   GASTROENTEROLOGY

865 PIANO: A 1000 Patient Prospective Registry of Pregnancy Outcomes in Women With IBD Exposed to Immunomodulators and Biologic Therapy

(2015) Uma Mahadevan et al.   GASTROENTEROLOGY

Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease

(2014) M. Seirafi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Safety issues of biologics in pregnant patients with rheumatic diseases

(2014) Monika Østensen   Annals of the New York Academy of Sciences

Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

(2014) Lorry G. Rubin et al.   CLINICAL INFECTIOUS DISEASES

B Cell Suppression in Newborn Following Treatment of Pregnant Diffuse Large B-cell Lymphoma Patient with Rituximab Containing Regimen

(2014) Prakas Kumar Mandal et al.   INDIAN JOURNAL OF PEDIATRICS

Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children

(2014) Martin Bortlik et al.   INFLAMMATORY BOWEL DISEASES

Anti-TNF-  Therapy May Cause Neonatal Neutropenia

(2014) T. Guiddir et al.   PEDIATRICS

Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease

(2013) Javier P Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Fetal outcomes after rituximab exposure in women with autoimmune vasculitis

(2013) William F Pendergraft et al.   ANNALS OF THE RHEUMATIC DISEASES

Biological Therapies for Rheumatoid Arthritis: Progress to Date

(2013) Gaurav Malviya et al.   BIODRUGS

Safety of TNF-α inhibitors during IBD pregnancy: a systematic review

(2013) Ole Haagen Nielsen et al.   BMC Medicine

Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases

(2013) Mario Ojeda-Uribe et al.   CLINICAL RHEUMATOLOGY

Role of IgG antibodies in association with placental function and immunologic diseases in human pregnancy

(2013) Antoine Malek   Expert Review of Clinical Immunology

Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum

(2013) M Ringelstein et al.   Multiple Sclerosis Journal

Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review

(2013) Renée M Marchioni   WORLD JOURNAL OF GASTROENTEROLOGY

Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy

(2012) T. Bessissow et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease

(2012) Uma Mahadevan et al.   Clinical Gastroenterology and Hepatology

Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure

(2012) Zuzana Zelinkova et al.   Clinical Gastroenterology and Hepatology

Infliximab and Adalimumab Use During Breastfeeding

(2012) Juliane Fritzsche et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Adalimumab levels in an infant

(2012) Mette Julsgaard et al.   Journal of Crohns & Colitis

Chicken pox infection in a three months old infant exposed in utero to Adalimumab

(2012) Anna Johnsson et al.   Journal of Crohns & Colitis

Can TNF inhibitors be administered during the third trimester?

(2012) Ole Haagen Nielsen et al.   Nature Reviews Gastroenterology & Hepatology

High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

(2011) Z. Zelinkova et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

TNF-α and the Development of the Neonatal Immune System: Implications for Inhibitor Use in Pregnancy

(2011) Razvan Arsenescu et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Hepatitis B Immunity and Response to Booster Vaccination in Children With Inflammatory Bowel Disease Treated With Infliximab

(2011) Jonathan Moses et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

IgG Placental Transfer in Healthy and Pathological Pregnancies

(2011) Patricia Palmeira et al.   Clinical & Developmental Immunology

Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-α inhibitors

(2011) Andreas Woerner et al.   Human vaccines & immunotherapeutics

Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease

(2011) Shomron Ben-Horin et al.   Journal of Crohns & Colitis

Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31

(2011) Casper Steenholdt et al.   Journal of Crohns & Colitis

Safety of infliximab use during pregnancy

(2011) Nada Djokanovic et al.   REPRODUCTIVE TOXICOLOGY

Clinical Immunology Review Series: An approach to the patient with recurrent infections in childhood

(2010) M. A. Slatter et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease

(2010) Kuldeep Cheent et al.   Journal of Crohns & Colitis

Apparent safe use of single dose rituximab for recalcitrant atopic dermatitis in the first trimester of a twin pregnancy

(2010) Pedro Ponte et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Vaccines in Immunocompromised Patients

(2010)   PEDIATRICS IN REVIEW

Safety of rituximab therapy during twins' pregnancy

(2010) E. Ton et al.   RHEUMATOLOGY

Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding

(2010) B. G. Berthelsen et al.   RHEUMATOLOGY

Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum

(2009) A Murashima et al.   ANNALS OF THE RHEUMATIC DISEASES

Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an α4 integrin inhibitor

(2009) Nancy G. Wehner et al.   BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY

Adalimumab Level in Breast Milk of a Nursing Mother

(2009) Shomron Ben–Horin et al.   Clinical Gastroenterology and Hepatology

Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab

(2009) HL Pellkofer et al.   Multiple Sclerosis Journal

Hepatitis B vaccines: WHO position paper—Recommendations

(2009)   VACCINE

Placental Transport of Immunoglobulins: A Clinical Review for Gastroenterologists Who Prescribe Therapeutic Monoclonal Antibodies to Women During Conception and Pregnancy

(2008) Sunanda V Kane et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Rituximab Administration in Third Trimester of Pregnancy Suppresses Neonatal B-Cell Development

(2008) D. T. Klink et al.   Clinical & Developmental Immunology

Is infliximab safe to use while breastfeeding?

(2008) Joel Z Stengel et al.   WORLD JOURNAL OF GASTROENTEROLOGY